AU2001272099A1 - Acetylsalicylic acid solutions - Google Patents

Acetylsalicylic acid solutions

Info

Publication number
AU2001272099A1
AU2001272099A1 AU2001272099A AU7209901A AU2001272099A1 AU 2001272099 A1 AU2001272099 A1 AU 2001272099A1 AU 2001272099 A AU2001272099 A AU 2001272099A AU 7209901 A AU7209901 A AU 7209901A AU 2001272099 A1 AU2001272099 A1 AU 2001272099A1
Authority
AU
Australia
Prior art keywords
acetylsalicylic acid
acid solutions
solutions
acetylsalicylic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001272099A
Inventor
Dietmar Bahn
Wolfgang Wiehl
Martina Wirtz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2001272099A1 publication Critical patent/AU2001272099A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
AU2001272099A 2000-03-07 2001-03-01 Acetylsalicylic acid solutions Abandoned AU2001272099A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10011032A DE10011032A1 (en) 2000-03-07 2000-03-07 Stable solutions of acetylsalicylic acid in mixture of organic solvent and water, useful for topical treatment of pain, especially pain associated with herpes zoster
DE10011032 2000-03-07
PCT/EP2001/002282 WO2001066115A2 (en) 2000-03-07 2001-03-01 Acetylsalicylic acid solutions

Publications (1)

Publication Number Publication Date
AU2001272099A1 true AU2001272099A1 (en) 2001-09-17

Family

ID=7633806

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001272099A Abandoned AU2001272099A1 (en) 2000-03-07 2001-03-01 Acetylsalicylic acid solutions

Country Status (9)

Country Link
EP (1) EP1263441A2 (en)
AR (1) AR028237A1 (en)
AU (1) AU2001272099A1 (en)
DE (1) DE10011032A1 (en)
GT (1) GT200100035A (en)
HN (1) HN2001000039A (en)
PE (1) PE20030207A1 (en)
SV (1) SV2002000339A (en)
WO (1) WO2001066115A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004315560A1 (en) * 2004-02-16 2005-08-25 Teikoku Seiyaku Co., Ltd Remedy for external use for skin and mucosal injuries caused by viral infection
RU2442578C2 (en) 2006-05-02 2012-02-20 Пфайнсмит С.А. (Пти) Лтд Acid complex
EP3630120A4 (en) * 2017-05-30 2021-01-13 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4219548A (en) * 1978-09-01 1980-08-26 The Procter & Gamble Company Topical anti-inflammatory composition
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
US5484606A (en) * 1994-01-24 1996-01-16 The Procter & Gamble Company Process for reducing the precipitation of difficulty soluble pharmaceutical actives
PL315635A1 (en) * 1994-01-24 1996-11-25 Procter & Gamble Method of solubilising hardly pharmaceutically active substances

Also Published As

Publication number Publication date
SV2002000339A (en) 2002-06-07
GT200100035A (en) 2001-12-18
PE20030207A1 (en) 2003-04-16
AR028237A1 (en) 2003-04-30
WO2001066115A2 (en) 2001-09-13
DE10011032A1 (en) 2001-09-13
WO2001066115A3 (en) 2002-02-14
HN2001000039A (en) 2001-07-09
EP1263441A2 (en) 2002-12-11

Similar Documents

Publication Publication Date Title
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AUPR109700A0 (en) Trading system
AU3388201A (en) Trading system
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2001265111A1 (en) Benzenedicarboxylic acid derivatives
AU2001244847A1 (en) Water-retaining structure
AU2001258349A1 (en) Bisacylguanidine
AU2001280167A1 (en) Novel propenohydroxamic acid derivatives
AU2765401A (en) Vial coupler
AU2002214978A1 (en) Beta-Thio-amino acids
AU2001258924A1 (en) Microsatellite-aflp
AU2001246864A1 (en) Hypotensors
AU2001282644A1 (en) Case
AU2001272099A1 (en) Acetylsalicylic acid solutions
AUPQ851000A0 (en) Rapid fatty acid delivery
AU4620300A (en) Can
AU2001260192A1 (en) Glycinamides
AU2001262711A1 (en) Cytoprotectors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001244628A1 (en) Pyroligneous acid
AU2001288067A1 (en) Phenylpropionic acid derivatives
AU2001256521A1 (en) Golf-putters
AU2001256287A1 (en) 2-phenyl-2h-pyridazine-3-ones